BIOMAT Database Logo BIOMAT Database Logo

A little more on lipoprotein profile in peripheral arterial disease. 1998

J Pedro-Botet, and J Rubiés-Prat, and M Sentí

UI MeSH Term Description Entries
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses
D016491 Peripheral Vascular Diseases Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART. Peripheral Angiopathies,Vascular Diseases, Peripheral,Diseases, Peripheral Vascular,Angiopathies, Peripheral,Angiopathy, Peripheral,Disease, Peripheral Vascular,Peripheral Angiopathy,Peripheral Vascular Disease,Vascular Disease, Peripheral
D017270 Lipoprotein(a) A lipoprotein that resembles the LOW-DENSITY LIPOPROTEINS but with an extra protein moiety, APOPROTEIN (A) also known as APOLIPOPROTEIN (A), linked to APOLIPOPROTEIN B-100 on the LDL by one or two disulfide bonds. High plasma level of lipoprotein (a) is associated with increased risk of atherosclerotic cardiovascular disease. Lipoprotein (a),Lipoprotein (a-),Lipoprotein Lp(a),Lipoprotein a

Related Publications

J Pedro-Botet, and J Rubiés-Prat, and M Sentí
[Lipoprotein profile estimated by nephelometry in peripheral arterial disease (author's transl)].
January 1974, Giornale italiano di cardiologia,
J Pedro-Botet, and J Rubiés-Prat, and M Sentí
Lipoprotein (a) in peripheral arterial occlusive disease.
January 1994, VASA. Zeitschrift fur Gefasskrankheiten,
J Pedro-Botet, and J Rubiés-Prat, and M Sentí
Plasma homocysteine and lipoprotein profile in patients with peripheral arterial occlusive disease.
March 2000, Angiology,
J Pedro-Botet, and J Rubiés-Prat, and M Sentí
Role of lipoprotein (a) in peripheral arterial disease.
September 2019, Annals of translational medicine,
J Pedro-Botet, and J Rubiés-Prat, and M Sentí
[Risk profile in peripheral arterial occlusive disease].
August 1985, Wiener medizinische Wochenschrift (1946),
J Pedro-Botet, and J Rubiés-Prat, and M Sentí
Altered gait profile in subjects with peripheral arterial disease.
January 2001, Vascular medicine (London, England),
J Pedro-Botet, and J Rubiés-Prat, and M Sentí
Normal platelet activation profile in patients with peripheral arterial disease on aspirin.
March 2015, Thrombosis research,
J Pedro-Botet, and J Rubiés-Prat, and M Sentí
Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
September 2006, International angiology : a journal of the International Union of Angiology,
J Pedro-Botet, and J Rubiés-Prat, and M Sentí
Low-density lipoprotein apheresis in the treatment of peripheral arterial disease.
August 2003, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
J Pedro-Botet, and J Rubiés-Prat, and M Sentí
Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results.
April 2019, Clinical research in cardiology supplements,
Copied contents to your clipboard!